Depression cuts longevity of cancer patients
The researchers found that symptoms of depression were the most consistent
psychological predictor of shortened survival in cancer patients.
Dr Kirk Warren Brown, from the University of Rochester in New York, and
colleagues used a number of factors to predict longevity in a group of 205
cancer patients over a 10-year period.
All the patients were newly diagnosed with cancer, with almost half of them
suffering from breast cancer.
At the end of the follow-up period, 125 were still alive and 80 had died from
cancer-related causes.
The team looked at various indicators of emotional state and coping, including
positive and negative mood, anxiety, stress, sense of control and depressive
symptoms.
After accounting for the effects of known demographic, medical risk and cancer
treatment factors, the researchers found that symptoms of depression were the
most consistent psychological predictor of shortened survival.
“The fact that depressive symptoms were shown to affect the course of cancer
in this study has important implications for psychological screening and
treatment of cancer patients,” says Dr Brown.
The researchers suggest that the first year after cancer diagnosis would be an
appropriate time to screen for symptoms of depression because, on average,
distress levels among the patients they looked at remained stable.
Referrals for intervention, such as psychotherapy, may be appropriate for
patients with elevated levels of distress, they suggest.
Source: Psychosomatic Medicine
© HMG Worldwide 2003
http://www.health-news.co.uk/